Ambea as an investment
- Growing need
- Market leader
- Quality and competence
- Growth
- Balanced risk
- Cash flow and dividends

The share
Key figures FY 2024
14’195 MSEK
Net sales
1’372 MSEK
EBITA
7%
Growth
9.7%
EBITA margin
News and press releases
Calendar
- Mar 112025-03-11 14:20Carnegie Healthcare Seminar 2025 in Stockholm
- Mar 202025-03-20 18:05Carnegie and the Montrose investor platform in Stockholm with live broadcast
- Mar 312025-03-31 07:00Annual Report 2024
- Apr 32025-04-03 09:00DNB Small and Medium Enterprises Conference 2025 in Oslo
Reports

Year-end report January–December 2024
Ambea ended the year with higher earnings and a positive trend in most business areas.

Annual report: Future-proof care
Annual report with quality & sustainability report 2023
CEO Mark Jensen about the year-end report 2024
CEO Mark Jensen presents the year-end report from Nytida’s daily activity centre Ateljé Lilla Frans in Stockholm.
IR Contact

Susanne Vogt
Head of IR
No matching results.